732936001: comprimé (unité de présentation)

SNOMED CT Concept\valeur de l'attribut\Unit of measure (qualifier value)\Unit of presentation (unit of presentation)\Tablet (unit of presentation)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Tablet (unit of presentation)	est un(e) (attribut)	Unit of presentation (unit of presentation)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Acetaminophen 650 mg and pentazocine 25 mg oral tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Acetaminophen 650 mg and pentazocine 25 mg oral tablet	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Product containing precisely clotrimazole 100 milligram/1 each conventional release vaginal tablet (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Product containing precisely clotrimazole 100 milligram/1 each conventional release vaginal tablet (clinical drug)	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Product containing precisely clotrimazole 200 milligram/1 each conventional release vaginal tablet (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Product containing precisely clotrimazole 200 milligram/1 each conventional release vaginal tablet (clinical drug)	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	2
Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Product containing precisely zolpidem tartrate 10 milligram/1 each conventional release sublingual tablet (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Product containing precisely zolpidem tartrate 10 milligram/1 each conventional release sublingual tablet (clinical drug)	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Product containing precisely zolpidem tartrate 10 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Product containing precisely zolpidem tartrate 10 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Product containing precisely zolpidem tartrate 5 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Product containing precisely zolpidem tartrate 5 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Zolpidem tartrate 5 mg sublingual tablet	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Zolpidem tartrate 5 mg sublingual tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Product containing precisely valproic acid 100 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Product containing precisely valproic acid 100 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Valproic acid (as divalproex sodium) 125 mg gastro-resistant oral tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Valproic acid (as divalproex sodium) 125 mg gastro-resistant oral tablet	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	2
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Benserazide 12.5 mg and levodopa 50 mg oral tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Benserazide 12.5 mg and levodopa 50 mg oral tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	2
Benserazide 12.5 mg and levodopa 50 mg oral tablet	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	2
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug)	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	2
Cefaclor anhydrous (as cefaclor) 250 mg chewable tablet	Has presentation strength denominator unit (attribute)	False	Tablet (unit of presentation)	Inferred relationship	Some	1
Cefaclor anhydrous (as cefaclor) 250 mg chewable tablet	Has unit of presentation	False	Tablet (unit of presentation)	Inferred relationship	Some
Amoxicillin anhydrous (as amoxicillin) 400 mg and clavulanic acid (as clavulanate potassium) 57 mg chewable tablet	Has presentation strength denominator unit (attribute)	False	Tablet (unit of presentation)	Inferred relationship	Some	2
Amoxicillin anhydrous (as amoxicillin) 400 mg and clavulanic acid (as clavulanate potassium) 57 mg chewable tablet	Has unit of presentation	False	Tablet (unit of presentation)	Inferred relationship	Some
Amoxicillin anhydrous (as amoxicillin) 400 mg and clavulanic acid (as clavulanate potassium) 57 mg chewable tablet	Has presentation strength denominator unit (attribute)	False	Tablet (unit of presentation)	Inferred relationship	Some	1
Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	3
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	3
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	2
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	2
Product containing precisely amoxicillin anhydrous (as amoxicillin) 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator unit (attribute)	False	Tablet (unit of presentation)	Inferred relationship	Some	1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator unit (attribute)	False	Tablet (unit of presentation)	Inferred relationship	Some	2
Product containing precisely amoxicillin anhydrous (as amoxicillin) 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug)	Has unit of presentation	False	Tablet (unit of presentation)	Inferred relationship	Some
Product containing precisely doxycycline monohydrate 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has unit of presentation	False	Tablet (unit of presentation)	Inferred relationship	Some
Product containing precisely doxycycline monohydrate 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator unit (attribute)	False	Tablet (unit of presentation)	Inferred relationship	Some	1
Amoxicillin anhydrous (as amoxicillin) 775 mg prolonged-release oral tablet	Has unit of presentation	False	Tablet (unit of presentation)	Inferred relationship	Some
Amoxicillin anhydrous (as amoxicillin) 775 mg prolonged-release oral tablet	Has presentation strength denominator unit (attribute)	False	Tablet (unit of presentation)	Inferred relationship	Some	1
Amoxicillin anhydrous (as amoxicillin) 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet	Has presentation strength denominator unit (attribute)	False	Tablet (unit of presentation)	Inferred relationship	Some	1
Amoxicillin anhydrous (as amoxicillin) 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet	Has unit of presentation	False	Tablet (unit of presentation)	Inferred relationship	Some
Amoxicillin anhydrous (as amoxicillin) 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet	Has presentation strength denominator unit (attribute)	False	Tablet (unit of presentation)	Inferred relationship	Some	2
Amoxicillin anhydrous (as amoxicillin) 250 mg chewable tablet	Has presentation strength denominator unit (attribute)	False	Tablet (unit of presentation)	Inferred relationship	Some	1
Amoxicillin anhydrous (as amoxicillin) 250 mg chewable tablet	Has unit of presentation	False	Tablet (unit of presentation)	Inferred relationship	Some
Product containing precisely clarithromycin 1 gram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Product containing precisely clarithromycin 1 gram/1 each prolonged-release oral tablet (clinical drug)	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Lanthanum (as lanthanum carbonate) 1 g chewable tablet	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Lanthanum (as lanthanum carbonate) 1 g chewable tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Mycophenolic acid (as mycophenolate sodium) 180 mg gastro-resistant oral tablet	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Deferasirox 250 mg tablet for oral suspension	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Deferasirox 250 mg tablet for oral suspension	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Product containing precisely deferasirox 125 milligram/1 each tablet for conventional release oral suspension (clinical drug)	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Product containing precisely deferasirox 125 milligram/1 each tablet for conventional release oral suspension (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Product containing precisely deferasirox 500 milligram/1 each tablet for conventional release oral suspension (clinical drug)	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Product containing precisely deferasirox 500 milligram/1 each tablet for conventional release oral suspension (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Product containing precisely magnesium aspartate 615 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Product containing precisely magnesium aspartate 615 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Mycophenolic acid (as mycophenolate sodium) 180 mg gastro-resistant oral tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Venetoclax 10 mg oral tablet	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Venetoclax 10 mg oral tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Venetoclax 50 mg oral tablet	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Venetoclax 50 mg oral tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Venetoclax 100 mg oral tablet	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Venetoclax 100 mg oral tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Product containing precisely ivosidenib 250 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Product containing precisely ivosidenib 250 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Alpelisib 50 mg oral tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Alpelisib 50 mg oral tablet	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Product containing precisely alpelisib 150 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Product containing precisely alpelisib 150 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Product containing precisely alpelisib 200 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Product containing precisely alpelisib 200 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Product containing precisely apremilast 20 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Product containing precisely apremilast 20 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1
Apremilast 10 mg oral tablet	Has unit of presentation	True	Tablet (unit of presentation)	Inferred relationship	Some
Apremilast 10 mg oral tablet	Has presentation strength denominator unit (attribute)	True	Tablet (unit of presentation)	Inferred relationship	Some	1

Start Previous Page 10 of 81 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3498396015	Tablet (unit of presentation)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3498397012	Tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
799361000241114	comprimé	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
799371000241118	comprimé (unité de présentation)	fr	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)